No Data
Maxim Group Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Express News | Citius Pharmaceuticals Inc : Maxim Group Adjusts Target Price to $8 From $100 to Reflect 1-for-25 Reverse Stock Split
US Stocks Mixed; Best Buy Posts Downbeat Earnings
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven?
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
104785770 : hope I'm wrong but seems like the wolfs tossing with this poor thing, up and down up and down for marginal profits.. then when come quarterly report, down another half, then same cycle again... just hope the on going product get approved by FDA in time to avoid the worst.
萬軍無兵策天鳳 104785770 : 跑吧，FDA批准了继续掉。这是个骗子公司来的，我已经看清了
104785770 : nope, I got into this because of your comment, I have my self to be blamed. but not falling into your words again. thanks but no thanks. if lose everything then il take it. i'll stop simply listen to stranger or who knows you're a runner for the wolfs.